Pfizer
This article was originally published in The Tan Sheet
Executive Summary
"Strong" sales growth of Sudafed, Benadryl, Zantac 75 and Lubriderm helped offset "a mild cough/cold season in Europe" in first quarter, firm tells analysts April 18. Warner-Lambert Consumer Group sales fell 2% to $591 mil. in period; excluding effect of currency exchange, segment revenues were flat. Consolidated revenues increased 7% to $7.65 bil., led by human pharmaceuticals sales, which jumped 11% to $6.05 bil. Overall sales growth was reduced by about 3% ($229 mil.) due to foreign exchange and roughly 2% ($103 mil.) as a result of the withdrawal of Rx diabetes drug Rezulin